DJIA 16,380.41 263.17 1.63%
NASDAQ 4,258.44 41.05 0.97%
S&P 500 1,886.76 24.00 1.29%
market minute promo

4.68 -0.17 (-3.51%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PGNX $4.68 -3.51%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.95
Previous Close $4.85
Daily Range $4.65 - $5.00
52-Week Range $3.10 - $7.45
Market Cap $325.5M
P/E Ratio -7.95
Dividend (Yield) $0.00 (0.0%)
Volume 755,079
Average Daily Volume 902,593
Current FY EPS -$0.01

Sector

Healthcare

Industry

Drugs

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

Progenics Gets $40M Milestone on FDA Approval of Relistor - Analyst Blog

Progenics Receives $40M Milestone Following FDA Approval of RELISTOR For OIC Patients With Chronic N

Progenics Receives $40M Milestone Following FDA Approval of RELISTOR For OIC Patients With Chronic Non-Cancer Pain

Progenics/Salix's Relistor Label Expanded in the U.S. - Analyst Blog

Progenics: Inexpensive Way To Win Big 3 Potential Ways

Progenics: Inexpensive Way To Win Big Three Potential Ways

Sector Update: Health Care Shares Flat in Pre-Market Trade

Sector Update: Health Care

Progenics' Azedra Found Positive in Phase II Follow-Up Data - Analyst Blog

Progenics' Azedra Found Positive in Phase II Follow-Up Data - Analyst Blog

Sector Update: Health Care Stocks Dropping; Early Progenic Gains Slip Away Despite Data Supporting M

Sector Update: Health Care Stocks Dropping; Early Progenic Gains Slip Away Despite Data Supporting More Testing of Cancer Drug

Sector Update: Health Care

See More PGNX News...

PGNX's Top Competitors

PGNX $4.68 (-3.51%)
Current stock: PGNX
BIIB $306.71 (1.31%)
Current stock: BIIB
AMGN $133.69 (2.48%)
Current stock: AMGN
CELG $88.12 (2.01%)
Current stock: CELG